The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) Post author:Sam Post published:September 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bay Area's Adamas Pharma Pays Big Bucks to Double HQ January 21, 2018 FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications May 25, 2017 Intralytix Receives FDA Regulatory Clearance For Phage-Based Shigella Technology April 6, 2017
FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications May 25, 2017